| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |